Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk

European Journal of Cancer Prevention

Volumn 14, Issue 3, 2005, Pages 223-230

  Park, J Y ^a   Chen, L ^a   Elahi, A ^a   Lazarus, P ^a   Tockman, M S ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Epoxide hydrolase; Genetic polymorphism; Lung cancer; Metabolism

Indexed keywords

EPOXIDE HYDROLASE; MICROSOME ENZYME; TOBACCO SMOKE;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; EPOXIDE HYDROLASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TOBACCO SMOKE POLLUTION;

EID: 20344405486     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200506000-00005     Document Type: Article

References (38)

1. Benhamou S, Benhamou E, Flamant R (1986). Lung cancer risk associated with cigar and pipe smoking. Int J Cancer 37: 825-829.
2. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A (1998). Association between lung cancer and microsornai epoxide hydrolase genotypes. Cancer Res 58: 5291-5293.
3. Gaedigk A, Spielberg SP, Grant DM (1994). Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics 4: 142-153.
4. Green VJ, Pirmohamed M, Kitteringham NR, et al. (1995). Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity. Biochem Pharmacol 50: 1353-1359.
5. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA (1999). Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 79: 168-171.
6. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ (1994). Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421-428.
7. Ishibe N, Wiencke JK, Zuo ZF, et al. (1997). Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. Cancer Epidemiol Biomarkers Prev 6: 1075-1080.
8. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, et al. (2000). High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 60: 534-536.
9. Kabat GC, Morabia A, Wynder EL (1991). Comparison of smoking habits of blacks and whites in a case-control study. Am J Public Health 81: 1483-1486.
10. Lancaster JM, Brownlee HA, Bell DA, et al. (1996). Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17: 160-162.
11. Lazarus P, Park JY (2000). Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol 36: 421-431.
12. Lee WJ, Brennan P, Boffetta P, et al. (2002). Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review. Biomarkers 7: 230-241.
13. Lin P, Wang SL, Wang HJ, et al. (2000). Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Br J Cancer 82: 852-857.
14. London SJ, Daly AK, Cooper J, et al. (1995). Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 87: 1246-1253.
15. London SJ, Daly AK, Leathart JB, et al. (1997). Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis 18: 1203-1214.
16. London SJ, Smart J, Daly AK (2000). Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer 28: 147-155.
17. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD (1995). Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4: 589-594.
18. Nakachi K, Imai K, Hayashi S, Kawajiri K (1993). Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-2999.
19. Omiecinski CJ, Aicher L, Holubkov R, Checkoway H (1993). Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3: 150-158.
20. Park JY, Muscat JE, Ren Q, et al. (1997). CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 6: 791-797.
21. Park JY, Muscat JE, Kaur T, et al. (2000). Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 10: 123-131.
22. Park JY, Schantz SP, Lazarus P (2003). Epoxide hydrolase genotype and orolaryngeal cancer risk: interaction with GSTM1 genotype. Oral Oncol 39: 483-490.
23. Phillips DH (1983). Fifty years of benzo(a)pyrene. Nature 303: 468-472.
24. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6: 733-743.
25. Rodriguez F, Jardi R, Costa X, et al. (2002). Detection of polymorphisms at exons 3 (Tyr113-His) and 4 (His139-Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis. Anal Biochem 308: 120-126.
26. Sandford AJ, Chagani T, Weir TD, et al. (2001). Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 163: 469-473.
27. Sanger F, Nicklen S, Coulson AR (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467.
28. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM (1993). The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16: 325-332.
29. Tockman MS, Anthonisen NR, Wright EC, Donithan MG (1987). Airways obstruction and the risk for lung cancer. Ann Intern Med 106: 512-518.
30. To-Figueras J, Gene M, Gomez-Catalan J, et al. (2001). Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Lett 173: 155-162.
31. Wu X, Gwyn K, Amos CI, et al. (2001). The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis 22: 923-928.
32. Yim JJ, Park GY, Lee CT, et al. (2000). Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 55: 121-125.
33. Yim JJ, Yoo CG, Lee CT, et al. (2002). Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans. Lung 180: 119-125.
34. Yin L, Pu Y, Liu TY, et al. (2001). Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydroiase and lung cancer risk in Nanjing, China. Lung Cancer 33: 133-141.
35. Yoshikawa M, Hiyama K, Ishioka S, et al. (2000). Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med 5: 49-53.
36. Zhang R, Zhang A, He Q, Lu B (2002). [Microsomal epoxide hydrolase gene polymorphism and susceptibility to chronic obstructive pulmonary disease in Han nationality of North China]. Zhonghua Nei Ke Za Zhi 41: 11-14.
37. Zhao H, Spitz MR, Gwyn KM, Wu X (2002). Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog 33: 99-104.
38. Zhou W, Thurston SW, Liu G, et al. (2001). The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol Biomarkers Prev 10: 461-466.